| Name | 4-methyl-7-[(5-thio-beta-D-xylopyranosyl)oxy]-2H-1-benzopyran-2-one |
|---|
| Description | Odiparcil (SB-424323) is an orally active beta-d-thioxyloside analog with antithrombotic activity associated with a reduced risk of adverse bleeding events. Odiparcil (SB-424323) is indirect thrombin inhibitor that exerts its anticoagulant effect through activation of antithrombin II (heparin cofactor II) [1][2]. |
|---|---|
| Related Catalog | |
| Target |
Thrombin[2] |
| References |
| Molecular Formula | C15H16O6S |
|---|---|
| Molecular Weight | 324.34900 |
| Exact Mass | 324.06700 |
| PSA | 125.43000 |
| LogP | 0.63580 |
| Vapour Pressure | 1.03E-13mmHg at 25°C |